AGIO News and Press, Agios Pharmaceuticals Inc. From 06/03/24

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 17.9% to $0.1179 on volume of 290,472,504 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 7.1% to $0.6248 on volume of 223,394,331 shares GameStop Corporation (GME) rose 21.0% to $28...

2024-06-03 16:00:09 ET Gregory Renza from RBC Capital issued a price target of $53.00 for AGIO on 2024-06-03 14:30:00. The adjusted price target was set to $53.00. At the time of the announcement, AGIO was trading at $44.26. The overall price target consensus is at $44.2...

CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the Goldman Sachs 45th Annual Global Healthcare Conf...

A look at the top 10 most actives in the United States Pineapple Energy Inc. (PEGY) rose 46.0% to $0.2601 on volume of 655,453,952 shares Sharps Technology Inc. (STSS) rose 141.4% to $0.5174 on volume of 299,690,189 shares Greenwave Technology Solutions Inc. (GWAV) fell 7.4% to $0.0786 on...

2024-05-28 14:00:06 ET Chris Raymond from Raymond James issued a price target of $45.00 for AGIO on 2024-05-28 10:46:00. The adjusted price target was set to $45.00. At the time of the announcement, AGIO was trading at $38.39. The overall price target consensus is at $44...

Shares of Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) traded at a new 52-week high today and are currently trading at $38.42. So far today, approximately 1.08M shares have been exchanged, as compared to an average 30-day volume of 616.52k shares. Agios Pharmaceuticals, Inc., a biopharmaceutica...

2024-05-28 10:00:33 ET More on Health Care Select Sector SPDR XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Short interest in S&P 500 ...

A look at the top 10 most actives in the United States Pineapple Energy Inc. (PEGY) rose 121.3% to $0.3941 on volume of 248,629,940 shares Sharps Technology Inc. (STSS) rose 184.6% to $0.61 on volume of 114,390,080 shares Crown Electrokinetics Corp. (CRKN) rose 31.2% to $0.1325 on volume ...

2024-05-28 07:45:02 ET More on Agios, Royalty Pharma, etc. Royalty Pharma: Solid Start Of The Year, Buy Confirmed Royalty Pharma PLC (RPRX) Q1 2024 Earnings Call Transcript Agios Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation Cytokinetic...

– Royalty Pharma to Acquire Rights to Agios’ 15% Royalty on Potential Vorasidenib U.S. Net Sales for $905 Million Upfront upon FDA Approval of Vorasidenib; Agios to Share in Economics Above Certain Revenue Thresholds – – Agios Retains Rights to $200 Million M...